Christine MacCracken is Director, Patient Support at the Janssen Pharmaceutical Companies of Johnson and Johnson where she leads strategic identification and implementation of patient-centered initiatives. In this role, she serves as key liaison to New York University School of Medicine and the Compassionate Use Advisory Committee (CompAC). Her focus is on raising organizational awareness around hearing the voice of the patient and recognizing “Every Patient is a Person First”.
Prior to joining the Johnson & Johnson Family of Companies in 2015, Christine was Senior Director, Business Insights at the National Comprehensive Cancer Network (NCCN).In support of people with cancer and the providers who treat them, she closely collaborated with industry, state oncology societies and advocacy groups to disseminate NCCN treatment information through health technology platforms as well as market and outcome research programs.
Christine’s strong passion around hearing the voice of the patient began at the Children’s Hospital of Philadelphia where she was an oncology nurse treating families with life changing diagnoses. With patients and their experience front of mind, she developed an interest in research and joined Radiation Therapy Oncology Group (RTOG) with a focus on quality of life studies. Bridging this interest with pharmaceutical development, she later joined Merck & Co., Inc. with increasing roles of responsibility in clinical research and academic affairs, ultimately sharing her collective experience as an adjunct professor.
Christine resides outside of Philadelphia with husband Tim, and the luckiest dog on earth, Jack. She holds a Bachelor of Science, Nursing from Holy Family University and Master’s Degree, Health Education from Arcadia University.